Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Maike Scherf-Clavel, Heike Weber, Jürgen Deckert & Angelika Erhardt-Lehmann. (2021) The role of pharmacogenetics in the treatment of anxiety disorders and the future potential for targeted therapeutics. Expert Opinion on Drug Metabolism & Toxicology 17:11, pages 1249-1260.
Read now
Read now
Margret R. Hoehe & Deborah J. Morris-Rosendahl. (2018) The role of genetics and genomics in clinical psychiatry. Dialogues in Clinical Neuroscience 20:3, pages 169-177.
Read now
Read now
MJ Arranz, C Gallego, J Salazar & B Arias. (2016) Pharmacogenetic studies of drug response in schizophrenia. Expert Review of Precision Medicine and Drug Development 1:1, pages 79-91.
Read now
Read now
Qiaoli Wang, Xiaotong Han, Jian Li, Xinghui Gao, Yan Wang, Mingzhou Liu, Guicheng Dong & Jiang Yue. (2015) Regulation of cerebral CYP2D alters tramadol metabolism in the brain: interactions of tramadol with propranolol and nicotine. Xenobiotica 45:4, pages 335-344.
Read now
Read now
Steven L Dubovsky. (2015) The usefulness of genotyping cytochrome P450 enzymes in the treatment of depression. Expert Opinion on Drug Metabolism & Toxicology 11:3, pages 369-379.
Read now
Read now
Amtul H. Changasi, Tahireh A. Shams, Jennie G. Pouget & Daniel J. Müller. (2014) Genetics of antipsychotic drug outcome and implications for the clinician: into the limelight. Translational Developmental Psychiatry 2:1.
Read now
Read now
Articles from other publishers (55)
Anindya Kar, Thomas Nutting, Mohammad Ikram & Charles Sullivan. (2023) The clozapine conundrum: Navigating neutropenia and the pursuit of effective care in treatment-resistant schizophrenia. The International Journal of Psychiatry in Medicine.
Crossref
Crossref
Maike Scherf-Clavel, Amelie Frantz, Andreas Eckert, Heike Weber, Stefan Unterecker, Jürgen Deckert, Andreas Reif & Martina Hahn. (2023) Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study. International Journal of Clinical Pharmacy 45:5, pages 1107-1117.
Crossref
Crossref
Wujie Ye, Jingyu Xing, Zekai Yu, Xingang Hu & Yan Zhao. (2023) Mechanism and treatments of antipsychotic-induced weight gain. International Journal of Obesity 47:6, pages 423-433.
Crossref
Crossref
Sarah M. Hutchison, Ursula Brain, Ruth E. Grunau, Boris Kuzeljevic, Mike Irvine, Louise C. Mâsse & Tim F. Oberlander. (2023) Associations between maternal depressive symptoms and selective serotonin reuptake inhibitor antidepressant treatment on internalising and anxiety behaviours in children: 12-year longitudinal study. BJPsych Open 9:2.
Crossref
Crossref
Hongliang Su, Lingxiao Wang, Amin Wurita, Chao Zhang, Miaomiao Wu, Bin Li, Weifen Niu, Youmei Wang, Zhiwen Wei & Keming Yun. (2023) A comparative study of postmortem distribution and postmortem diffusion of tramadol in rabbits. Scientific Reports 13:1.
Crossref
Crossref
Aminah Alchakee, Munazza Ahmed, Leen Eldohaji, Hamid Alhaj & Maha Saber-Ayad. (2022) Pharmacogenomics in Psychiatry Practice: The Value and the Challenges. International Journal of Molecular Sciences 23:21, pages 13485.
Crossref
Crossref
Duncan Honeycutt, Melissa DelBello, Jeffrey Strawn, Laura Ramsey, Luis Patino, Kyle Hinman, Jeffrey Welge, David Miklowitz, Booil Jo, Thomas Blom, Kaitlyn Bruns, Sarah Hamill Skoch, Nicole Starace, Maxwell Tallman & Manpreet Singh. (2022) A Double-Blind Randomized Trial to Investigate Mechanisms of Antidepressant-Related Dysfunctional Arousal in Depressed or Anxious Youth at Familial Risk for Bipolar Disorder. Journal of Personalized Medicine 12:6, pages 1006.
Crossref
Crossref
Diane Merino, Arnaud Fernandez, Alexandre O. Gérard, Nouha Ben Othman, Fanny Rocher, Florence Askenazy, Céline Verstuyft, Milou-Daniel Drici & Susanne Thümmler. (2022) Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review. Pharmaceuticals 15:6, pages 749.
Crossref
Crossref
Maria J. Arranz, Juliana Salazar, Valentin Bote, Alicia Artigas-Baleri, Alexandre Serra-LLovich, Emma Triviño, Jordi Roige, Carlos Lombardia, Martha Cancino, Marta Hernandez, Marc Cendros, Enric Duran-Tauleria, Natalia Maraver & Amaia Hervas. (2022) Pharmacogenetic Interventions Improve the Clinical Outcome of Treatment-Resistant Autistic Spectrum Disorder Sufferers. Pharmaceutics 14:5, pages 999.
Crossref
Crossref
Catriona Hippman, Caitlin Slomp, Emily Morris, Rolan Batallones, Angela Inglis, Prescilla Carrion, Ursula Brain, Michelle Higginson, Galen E. B. Wright, Lynda G. Balneaves, Deirdre Ryan, Corey Nislow, Colin J. D. Ross, Andrea Gaedigk, Tim F. Oberlander & Jehannine Austin. (2021) A cross-sectional study of the relationship between CYP2D6 and CYP2C19 variations and depression symptoms, for women taking SSRIs during pregnancy. Archives of Women's Mental Health 25:2, pages 355-365.
Crossref
Crossref
Samad Safiloo, Yadollah Mehrabi, Sareh Asadi & Soheila Khodakarim. (2021) Response to Fluvoxamine in the Obsessive-Compulsive Disorder Patients: Bayesian Ordinal Quantile Regression. Clinical Practice & Epidemiology in Mental Health 17:1, pages 146-151.
Crossref
Crossref
Hongliang Su, Yongjun Li, Miaomiao Wu, Tingting Sun, Weifen Niu, Juan Jia, Zhiwen Wei & Keming Yun. (2021) Dynamic Distribution and Postmortem Redistribution of Tramadol in Poisoned Rats. Journal of Analytical Toxicology 45:2, pages 203-210.
Crossref
Crossref
Gwyneth Zai. 2021. The Neurobiology and Treatment of OCD: Accelerating Progress. The Neurobiology and Treatment of OCD: Accelerating Progress
385
398
.
Xiaoxiao Shan, Wenli Zhao, Yan Qiu, Haishan Wu, Jindong Chen, Yiru Fang, Wenbin Guo & Lehua Li. (2019) Preliminary Clinical Investigation of Combinatorial Pharmacogenomic Testing for the Optimized Treatment of Depression: A Randomized Single-Blind Study. Frontiers in Neuroscience 13.
Crossref
Crossref
Lucas M. Walden, Eva J. Brandl, Arun K. Tiwari, Sheraz Cheema, Natalie Freeman, Nicole Braganza, James L. Kennedy & Daniel J. Müller. (2019) Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication. Psychiatry Research 279, pages 111-115.
Crossref
Crossref
Maria J. Arranz, Alex Gonzalez-Rodriguez, Josefina Perez-Blanco, Rafael Penadés, Blanca Gutierrez, Laura Ibañez, Barbara Arias, Mercè Brunet, Jorge Cervilla, Juliana Salazar & Rosa Catalan. (2019) A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments. Translational Psychiatry 9:1.
Crossref
Crossref
Ethan A. PoweleitStacey L. AldrichLisa J. MartinDavid HahnJeffrey R. StrawnLaura B. Ramsey. (2019) Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive Disorders. Journal of Child and Adolescent Psychopharmacology 29:5, pages 348-361.
Crossref
Crossref
L. K. Khokhlov & N. E. Lukyanov. (2019) Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies. Acta Biomedica Scientifica (East Siberian Biomedical Journal) 4:2, pages 33-43.
Crossref
Crossref
Stacey L. Aldrich, Ethan A. Poweleit, Cynthia A. Prows, Lisa J. Martin, Jeffrey R. Strawn & Laura B. Ramsey. (2019) Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders. Frontiers in Pharmacology 10.
Crossref
Crossref
Xenia Gonda, Peter Petschner, Nora Eszlari, Daniel Baksa, Andrea Edes, Peter Antal, Gabriella Juhasz & Gyorgy Bagdy. (2019) Genetic variants in major depressive disorder: From pathophysiology to therapy. Pharmacology & Therapeutics 194, pages 22-43.
Crossref
Crossref
Haley V. Solomon, Kevin W. Cates & Kevin J. Li. (2019) Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions?. Psychiatry Research 271, pages 604-613.
Crossref
Crossref
Gouri Mukerjee, Andrea Huston, Boyko Kabakchiev, Micheline Piquette-Miller, Ron van Schaik & Ruslan Dorfman. (2018) User considerations in assessing pharmacogenomic tests and their clinical support tools. npj Genomic Medicine 3:1.
Crossref
Crossref
Erik J. GroesslSteven R. TallyNaomi HilleryAlejandra MacielJorge A. Garces. (2018) Cost-Effectiveness of a Pharmacogenetic Test to Guide Treatment for Major Depressive Disorder. Journal of Managed Care & Specialty Pharmacy 24:8, pages 726-734.
Crossref
Crossref
D. J. Müller, E. J. Brandl, F. Degenhardt, K. Domschke, H. Grabe, O. Gruber, J. Hebebrand, W. Maier, A. Menke, M. Riemenschneider, M. Rietschel, D. Rujescu, T. G. Schulze, L. Tebartz van Elst, O. Tüscher & J. Deckert. (2018) Pharmakogenetik in der Psychiatrie: eine StandortbestimmungPharmacogenetics in psychiatry: state of the art. Der Nervenarzt 89:3, pages 290-299.
Crossref
Crossref
Paul Bradley, Michael Shiekh, Vishaal Mehra, Keith Vrbicky, Stacey Layle, Marilyn C. Olson, Alejandra Maciel, Ali Cullors, Jorge A. Garces & Andrew A. Lukowiak. (2018) Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility. Journal of Psychiatric Research 96, pages 100-107.
Crossref
Crossref
Salma Malik, Sophia A. Walker, Sasha Malik & Lisa Namerow. 2018. Understanding Uniqueness and Diversity in Child and Adolescent Mental Health. Understanding Uniqueness and Diversity in Child and Adolescent Mental Health
239
261
.
Manish K. Jha & Madhukar H. Trivedi. 2019. Antidepressants. Antidepressants
101
113
.
Víctor Pérez, Ariana Salavert, Jordi Espadaler, Miquel Tuson, Jerónimo Saiz-Ruiz, Cristina Sáez-Navarro, Julio Bobes, Enrique Baca-García, Eduard Vieta, José M. Olivares, Roberto Rodriguez-Jimenez, José M. Villagrán, Josep Gascón, Josep Cañete-Crespillo, Montse Solé, Pilar A. Saiz, Ángela Ibáñez, Javier de Diego-Adeliño & José M. Menchón. (2017) Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial. BMC Psychiatry 17:1.
Crossref
Crossref
Mingzhou Liu, Peng Wang, Xuming Yu, Guicheng Dong & Jiang Yue. (2017)
Intracerebral microdialysis coupled to LC-MS/MS for the determination tramadol and its major pharmacologically active metabolite
O
-desmethyltramadol in rat brain microdialysates
. Drug Testing and Analysis 9:8, pages 1243-1250.
Crossref
Crossref
J. Kevin Hicks & Howard L. McLeod. 2017. Genomic and Precision Medicine. Genomic and Precision Medicine
89
107
.
Tristram A. Lett, Henrik Walter & Eva J. Brandl. (2016) Pharmacogenetics and Imaging–Pharmacogenetics of Antidepressant Response: Towards Translational Strategies. CNS Drugs 30:12, pages 1169-1189.
Crossref
Crossref
Aizati Daud, Jorieke Bergman, Wilhelmina Kerstjens-Frederikse, Henk Groen & Bob Wilffert. (2016) The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors—Is Pharmacogenetics the Key?. International Journal of Molecular Sciences 17:8, pages 1333.
Crossref
Crossref
Q Xu, X Wu, M Li, H Huang, C Minica, Z Yi, G Wang, L Shen, Q Xing, Y Shi, L He & S Qin. (2015) Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population. The Pharmacogenomics Journal 16:4, pages 357-365.
Crossref
Crossref
P M Bet, E C Verbeek, Y Milaneschi, D B M Straver, T Uithuisje, M R Bevova, J G Hugtenburg, P Heutink, B W J H Penninx & W J G Hoogendijk. (2015) A common polymorphism in the ABCB1 gene is associated with side effects of PGP-dependent antidepressants in a large naturalistic Dutch cohort. The Pharmacogenomics Journal 16:2, pages 202-208.
Crossref
Crossref
Rebecca L Andersen, Daniel J Johnson & Jai N Patel. (2016) Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways. Pharmacogenomics 17:4, pages 417-434.
Crossref
Crossref
Olalla Maroñas, Ana Latorre, Joaquín Dopazo, Munir Pirmohamed, Cristina Rodríguez-Antona, Gérard Siest, Ángel Carracedo & Adrián LLerena. (2016) Progress in pharmacogenetics: consortiums and new strategies. Drug Metabolism and Personalized Therapy 31:1, pages 17-23.
Crossref
Crossref
Steven L. Dubovsky. (2016) The Limitations of Genetic Testing in Psychiatry. Psychotherapy and Psychosomatics 85:3, pages 129-135.
Crossref
Crossref
María J. Arranz, Josefina Perez Blanco & Barbara Arias Samperiz. 2016. Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders. Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders
1
20
.
Alessandro Serretti & Chiara Fabbri. 2016. Pharmacovigilance in Psychiatry. Pharmacovigilance in Psychiatry
121
146
.
C A Altar, J M Carhart, J D Allen, D K Hall-Flavin, B M Dechairo & J G Winner. (2015) Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes. The Pharmacogenomics Journal 15:5, pages 443-451.
Crossref
Crossref
Steven L. Dubovsky & Amelia N. Dubovsky. (2015) The Role of Pharmacogenomics to Guide Treatment in Mood and Anxiety Disorders. Current Behavioral Neuroscience Reports 2:3, pages 154-164.
Crossref
Crossref
JK Hicks, JR Bishop, K Sangkuhl, DJ Müller, Y Ji, SG Leckband, JS Leeder, RL Graham, DL Chiulli, A LLerena, TC Skaar, SA Scott, JC Stingl, TE Klein, KE Caudle & A Gaedigk. (2015)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for
CYP2D6
and
CYP2C19
Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
. Clinical Pharmacology & Therapeutics 98:2, pages 127-134.
Crossref
Crossref
Sarah G Helton & Falk W Lohoff. (2015) Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders. Pharmacogenomics 16:5, pages 541-553.
Crossref
Crossref
Carmela Thompson, Steven P. Hamilton & Catriona Hippman. (2015) Psychiatrist attitudes towards pharmacogenetic testing, direct-to-consumer genetic testing, and integrating genetic counseling into psychiatric patient care. Psychiatry Research 226:1, pages 68-72.
Crossref
Crossref
Teri Smith, Susan Sharp, Ann Manzardo & Merlin Butler. (2015) Pharmacogenetics Informed Decision Making in Adolescent Psychiatric Treatment: A Clinical Case Report. International Journal of Molecular Sciences 16:3, pages 4416-4428.
Crossref
Crossref
Min-Ying Sun, Hong-Yan Du, An-Na Zhu, Hui-Ying Liang, Gorka de Garibay, Fen-Xia Li, Ming Li & Xue-Xi Yang. (2015) Genetic Polymorphisms in Estrogen-Related Genes and the Risk of Breast Cancer among Han Chinese Women. International Journal of Molecular Sciences 16:2, pages 4121-4135.
Crossref
Crossref
C. Anthony Altar, Joseph Carhart, Josiah D. Allen, Daniel Hall-Flavin, Joel Winner & Bryan Dechairo. (2015) Clinical Utility of Combinatorial Pharmacogenomics-Guided Antidepressant Therapy: Evidence from Three Clinical Studies. Complex Psychiatry 1:3, pages 145-155.
Crossref
Crossref
Eva J. Brandl, Nabilah I. Chowdhury, Arun K. Tiwari, Tristram A. P. Lett, Herbert Y. Meltzer, James L. Kennedy & Daniel J. Müller. (2014) Genetic variation in CYP3A43 is associated with response to antipsychotic medication. Journal of Neural Transmission 122:1, pages 29-34.
Crossref
Crossref
Ali J. Olyaei, Edgar V. Lerma, Sascha A. Tuchman & Matthew A. Sparks. 2015. Onconephrology. Onconephrology
105
129
.
Caterina Iofrida, Sara Palumbo & Silvia Pellegrini. (2014) Molecular genetics and antisocial behavior: Where do we stand?. Experimental Biology and Medicine 239:11, pages 1514-1523.
Crossref
Crossref
Tahireh A. Shams & Daniel J. Müller. (2014) Antipsychotic Induced Weight Gain: Genetics, Epigenetics, and Biomarkers Reviewed. Current Psychiatry Reports 16:10.
Crossref
Crossref
Gwyneth Zai, Eva J Brandl, Daniel J Müller, Margaret A Richter & James L Kennedy. (2014) Pharmacogenetics of antidepressant treatment in obsessive–compulsive disorder: an update and implications for clinicians. Pharmacogenomics 15:8, pages 1147-1157.
Crossref
Crossref
Mark D Brennan. (2014) Pharmacogenetics of second-generation antipsychotics. Pharmacogenomics 15:6, pages 869-884.
Crossref
Crossref
W D Dotson, M P Douglas, K Kolor, A C Stewart, M S Bowen, M Gwinn, A Wulf, H M Anders, C Q Chang, M Clyne, T K Lam, S D Schully, M Marrone, W G Feero & M J Khoury. (2014) Prioritizing Genomic Applications for Action by Level of Evidence: A Horizon-Scanning Method. Clinical Pharmacology & Therapeutics 95:4, pages 394-402.
Crossref
Crossref
Kathryn R. Gardner, Francis X. Brennan, Rachel Scott & Jay Lombard. (2014) The Potential Utility of Pharmacogenetic Testing in Psychiatry. Psychiatry Journal 2014, pages 1-6.
Crossref
Crossref